Phase
Condition
Osteopenia
Treatment
N/AClinical Study ID
Ages 55-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
BMD T-scores of the hip (femoral neck or trochanter)and/or spine between -1.0 and -2.5;
pattern differentiation is kidney deficiency in TCM.
informed consent.
Exclusion
Exclusion Criteria:
Osteoporotic (T-score< -2.5) at any site or a fracture in the past 2 years not causedby motor vehicle accident;
prior or current use of medication that increase risks of fracture (e.g. steroids,anti-convulsants, anticoagulants,lithium);
prior or current use of medications that modify bone metabolism (e.g. bisphosphonates,selective estrogen receptor modulators such as Raloxifene);
use of calcium supplements above levels suggested within the recommendations ofstandard care (i.e., above 1200-1500 mg);
current or prior year use of estrogen or calcitonin;
Malignancies other than skin cancer;
conditions that cause secondary osteoporosis (e.g. Cushing's syndrome, Marfan'ssyndrome);
lactation and gestational period;
physical or mental disabilities that will preclude informed consent or active studyparticipation;
supersensitivity body constitution.
osteoporotic fracture of having operating indication.
Study Design
Study Description
Connect with a study center
Longhua Hospital
Shanghai, Shanghai 200032
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.